189 related articles for article (PubMed ID: 24745694)
1. Introduction of postabortion contraception, prioritizing long-acting reversible contraceptives, in the principal maternity hospital of Gabon.
Mayi-Tsonga S; Obiang PA; Minkobame U; Ngouafo D; Ambounda N; de Souza MH
Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S45-8. PubMed ID: 24745694
[TBL] [Abstract][Full Text] [Related]
2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
3. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
4. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
5. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
6. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
Rose SB; Garrett SM
J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
[TBL] [Abstract][Full Text] [Related]
7. Contraception following abortion and the treatment of incomplete abortion.
Gemzell-Danielsson K; Kopp Kallner H; Faúndes A
Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S52-5. PubMed ID: 24739476
[TBL] [Abstract][Full Text] [Related]
8. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
Krashin JW; Stuart GS; Garrett J; Spector H; Bryant AG; Charm S; Morse JE
Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755
[TBL] [Abstract][Full Text] [Related]
9. Impact of long-acting reversible contraception on return for repeat abortion.
Rose SB; Lawton BA
Am J Obstet Gynecol; 2012 Jan; 206(1):37.e1-6. PubMed ID: 21944222
[TBL] [Abstract][Full Text] [Related]
10. Twenty-four-month continuation of reversible contraception.
O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
[TBL] [Abstract][Full Text] [Related]
11. Immediate postabortion access to IUDs, implants and DMPA reduces repeat pregnancy within 1 year in a New York City practice.
Langston AM; Joslin-Roher SL; Westhoff CL
Contraception; 2014 Feb; 89(2):103-8. PubMed ID: 24309218
[TBL] [Abstract][Full Text] [Related]
12. Attitudes toward long-acting reversible contraception among young women seeking abortion.
Rose SB; Cooper AJ; Baker NK; Lawton B
J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
[TBL] [Abstract][Full Text] [Related]
13. Administration of depot medroxyprogesterone acetate on the day of mifepristone for medical abortion: a pilot study.
Sonalkar S; McClusky J; Hou MY; Borgatta L
Contraception; 2015 Feb; 91(2):174-7. PubMed ID: 25481376
[TBL] [Abstract][Full Text] [Related]
14. Uptake and adherence to long-acting reversible contraception post-abortion.
Rose SB; Lawton BA; Brown SA
Contraception; 2010 Oct; 82(4):345-53. PubMed ID: 20851228
[TBL] [Abstract][Full Text] [Related]
15. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Rose SB; Garrett SM; Stanley J
Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
[TBL] [Abstract][Full Text] [Related]
16. Plan A: postabortion contraception.
Micks E; Prager S
Clin Obstet Gynecol; 2014 Dec; 57(4):751-62. PubMed ID: 25254920
[TBL] [Abstract][Full Text] [Related]
17. Long-acting contraceptive options.
Kaunitz AM
Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive discontinuation and pregnancy postabortion in Nepal: a longitudinal cohort study.
Puri M; Henderson JT; Harper CC; Blum M; Joshi D; Rocca CH
Contraception; 2015 Apr; 91(4):301-7. PubMed ID: 25553872
[TBL] [Abstract][Full Text] [Related]
19. Trends and determinants of postabortion contraception use in a Canadian retrospective cohort.
Burk JC; Norman WV
Contraception; 2019 Aug; 100(2):96-100. PubMed ID: 31100218
[TBL] [Abstract][Full Text] [Related]
20. Depot-medroxyprogesterone acetate contraception use among Salvadoran women: an in-depth analysis of attitudes and experiences.
Cremer M; Ditzian L; April A; Peralta E; Klausner D; Podolsky R; Dierking E
J Womens Health (Larchmt); 2011 Nov; 20(11):1751-6. PubMed ID: 21823919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
